These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38176219)

  • 1. Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysis.
    Al-Salihi MM; Saha R; Ayyad A; Al-Jebur MS; Al-Salihi Y; Roy A; Dalal SS; Rivet D; Spiotta AM; Qureshi AI
    Clin Neurol Neurosurg; 2024 Jan; 236():108097. PubMed ID: 38176219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).
    Berekashvili K; Soomro J; Shen L; Misra V; Chen PR; Blackburn S; Dannenbaum M; Grotta JC; Barreto AD
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3647-3651. PubMed ID: 30249518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke.
    Adeoye O; Broderick J; Derdeyn CP; Grotta JC; Barsan W; Bentho O; Berry S; Concha M; Davis I; Demel S; Elm J; Gentile N; Graves T; Hoffman M; Huang J; Ingles J; Janis S; Jasne AS; Khatri P; Levine SR; Majjhoo A; Panagos P; Pancioli A; Pizzella S; Ranasinghe T; Sabagha N; Sivakumar S; Streib C; Vagal A; Wilson A; Wintermark M; Yoo AJ; Barreto AD
    N Engl J Med; 2024 Sep; 391(9):810-820. PubMed ID: 39231343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): Rationale and design.
    Yang Y; Zhou Z; Pan Y; Chen H; Wang Y;
    Am Heart J; 2020 Jul; 225():38-43. PubMed ID: 32485328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
    Barreto AD; Ford GA; Shen L; Pedroza C; Tyson J; Cai C; Rahbar MH; Grotta JC;
    Stroke; 2017 Jun; 48(6):1608-1616. PubMed ID: 28507269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis.
    Goh S; Tan NHW; Tan CH; Leow AST; Sia CH; Ho AFW; Lim MJR; Yeo LLL; Tan BYQ
    J Thromb Thrombolysis; 2022 Feb; 53(2):485-494. PubMed ID: 34302590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of endovascular treatment with or without intravenous alteplase in acute anterior circulation large vessel occlusion stroke: a meta-analysis of randomized controlled trials.
    Zhang J; Yuan C; Deng X; Yuan Q; Wang M; Fu P; Fang J; Du Z; Hu J
    Neurol Sci; 2022 Jun; 43(6):3551-3563. PubMed ID: 35314911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Barreto AD; Alexandrov AV; Lyden P; Lee J; Martin-Schild S; Shen L; Wu TC; Sisson A; Pandurengan R; Chen Z; Rahbar MH; Balucani C; Barlinn K; Sugg RM; Garami Z; Tsivgoulis G; Gonzales NR; Savitz SI; Mikulik R; Demchuk AM; Grotta JC
    Stroke; 2012 Mar; 43(3):770-5. PubMed ID: 22223235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Dai YJ; Li GH; Peng ZL; Zhang Y; Liu XD; Yuan ZM; Jiang CH; Yang QC; Duan YJ; Ma GB; Zhao LW; Wang RX; Sun YL; Shen L; Wang EQ; Wang LH; Feng YF; Wang FY; Zou RL; Yang HP; Wang K; Wang DL; Wang YL;
    JAMA; 2023 Feb; 329(8):640-650. PubMed ID: 36757755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
    Liu S; Liu P; Wang P; Zhang F; Wang L; Wang Y; Lu H; Ma X
    Med Sci Monit; 2020 Jul; 26():e924593. PubMed ID: 32667287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomized Clinical Trial.
    Zhang X; Zhong W; Xue R; Jin H; Gong X; Huang Y; Chen F; Chen M; Gu L; Ge Y; Ma X; Zhong B; Wang M; Hu H; Chen Z; Yan S; Chen Y; Wang X; Zhang X; Xu D; He Y; Lou M; Wang A; Zhang X; Ma L; Lu X; Wang J; Lou Q; Qian P; Xie G; Zhu X; He S; Hu J; Wen X; Liu Y; Wang Y; Fu J; Fan W; Liebeskind D; Yuan C; Lou M
    JAMA Neurol; 2024 Feb; 81(2):118-125. PubMed ID: 38190136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression.
    Xie H; Chen Y; Ge W; Xu X; Liu C; Lan Z; Yang Y
    PLoS One; 2024; 19(2):e0298226. PubMed ID: 38412157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis.
    Liu Q; Lu X; Yang H; Deng S; Zhang J; Chen S; Shi S; Xun W; Peng R; Lin B; Li T; Pan L; Weng B
    Clin Neurol Neurosurg; 2022 Nov; 222():107449. PubMed ID: 36162161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
    Jang IK; Brown DF; Giugliano RP; Anderson HV; Losordo D; Nicolau JC; Dutra OP; Bazzino O; Viamonte VM; Norbady R; Liprandi AS; Massey TJ; Dinsmore R; Schwarz RP
    J Am Coll Cardiol; 1999 Jun; 33(7):1879-85. PubMed ID: 10362188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most?: A systematic review and meta-analysis.
    Yang W; Zhang L; Yao Q; Chen W; Yang W; Zhang S; He L; Li H; Zhang Y
    Medicine (Baltimore); 2020 May; 99(20):e20187. PubMed ID: 32443338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical Thrombectomy and Intravenous Thrombolysis in Patients with Acute Stroke: A Systematic Review and Network Meta-Analysis.
    Matsumoto S; Mikami T; Iwagami M; Briasoulis A; Ikeda T; Takagi H; Kuno T
    J Stroke Cerebrovasc Dis; 2022 Jul; 31(7):106491. PubMed ID: 35468495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular thrombectomy and intra-arterial interventions for acute ischaemic stroke.
    Roaldsen MB; Jusufovic M; Berge E; Lindekleiv H
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD007574. PubMed ID: 34125952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy.
    Abbas A; Hamad AA; El Din Moawad MH; Ewis DK; Youssef RA; Hamouda H; Hassan MA; Aladawi M; Elfil M; Meshref M; Al-Mufti F
    J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107704. PubMed ID: 38561167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.